Avinger Inc is a United States-based company. The Company operates as a medical device company that designs, manufactures, and sells image-guided, catheter-based systems for treating peripheral artery disease (PAD). Its products are used by interventional cardiologists, vascular surgeons, and interventional radiologists in the United States and select international markets and are based on its Lumivascular platform, a system that uses optical coherence tomography (OCT) for real-time visualization inside arteries. Its products includes the Lightbox imaging console, Ocelot and Tigereye catheters for crossing blockages, and Pantheris for removing plaque.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

20/02/25	Avinger, Inc.(NasdaqCM:AVGR) dropped from S&P TMI Index	CI
17/02/25	Avinger, Inc.(NasdaqCM:AVGR) dropped from NASDAQ Composite Index	CI

Market Cap	2.71M 2.34M 2.19M 2.01M 3.79M 258M 3.84M 25.72M 10.09M 129M 10.17M 9.94M 427M	P/E 2022	-0.25x	P/E 2023	-0.19x
Enterprise Value	12.83M 11.11M 10.35M 9.51M 17.98M 1.22B 18.21M 122M 47.81M 610M 48.17M 47.11M 2.02B	EV / Sales 2022	1.19x	EV / Sales 2023	1.78x
Free-Float	88.44%	Yield 2022 *	-	Yield 2023	-

20/02/25	Avinger, Inc.(NasdaqCM:AVGR) dropped from S&P TMI Index	CI
17/02/25	Avinger, Inc.(NasdaqCM:AVGR) dropped from NASDAQ Composite Index	CI
11/02/25	Avinger Inc Terminated Employment Of Each Of Jeffrey M. Soinski, Co's CEO And Nabeel Subainati, Vice President, Finance	RE
11/02/25	Avinger, Inc. Announces Termination of the Employment of Jeffrey M. Soinski, Chief Executive Officer	CI
11/02/25	Avinger, Inc. Announces Executive Changes	CI
24/12/24	Wall Street Set to Open Mixed Tuesday Ahead of Holiday Break	MT
24/12/24	US Futures Tread Water Ahead of Holiday Break	MT
24/12/24	Iberdrola Completes Merger with Avangrid	MT
08/11/24	Avinger, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
08/11/24	Earnings Flash (AVGR) AVINGER Reports Q3 Loss $-1.82	MT
08/11/24	Earnings Flash (AVGR) AVINGER Posts Q3 Revenue $1.7M	MT
08/11/24	Avinger, Inc., Q3 2024 Earnings Call, Nov 07, 2024
04/10/24	Wall Street Set to Open Higher Friday on Strong Employment Data	MT

21/04/23	HC Wainwright Starts Avinger at Buy With $1.60 Price Target	MT
11/05/22	B. Riley Lowers Avinger's Price Target to $9 from $11, Keeps Buy Rating	MT
18/03/22	B. Riley Adjusts Avinger's Price Target to Post-Split $11 from $40, Expects Omicron Impact Late in Q4, Into Q1; Keeps Buy Rating	MT
29/06/21	AVINGER : B. Riley Starts Avinger at Buy with $2.50 PT, Says Well-Positioned to Execute on Growth Strategy	MT

02/01/25	Avinger : Private Placement Form 8 K	PU
08/11/24	Avinger : Quarterly Report for Quarter Ending September 30, 2024 (Form 10-Q)	PU
08/11/24	Avinger : Reports Third Quarter 2024 Results Form 8 K	PU
08/11/24	Avinger: Q3 Earnings Snapshot	AQ
25/10/24	Avinger Releases Updated Data from IMAGE-BTK in Webinar Featuring Key Opinion Leaders in the Field of Vascular Intervention	AQ

AVINGER Stock Nasdaq

Stocks

Advanced Medical Equipment & Technology

Valuation: AVINGER

Latest news : AVINGER

Analysts' recommendations: AVINGER

Press Releases: AVINGER

Managers and Directors: AVINGER

Medical Imaging Systems

Financials

Company Profile

Manager	Title	Age	Since
Karina Yamamoto CEO	Chief Executive Officer	-	-
Thomas Davis CTO	Chief Tech/Sci/R&D Officer	-	05/08/2024

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.	-0.84%	+5.24%	-13.34%	-16.71%	14.02B
IRAY GROUP	+4.81%	-6.82%	+38.55%	-12.19%	3.9B
SONOSCAPE MEDICAL CORP.	+1.81%	+11.70%	-36.35%	-55.26%	1.27B
BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD.	+1.98%	+9.99%	-35.86%	-43.67%	1.18B
IRADIMED CORPORATION	-4.57%	-3.84%	+37.31%	+107.77%	1.16B
SHANTOU INSTITUTE OF ULTRASONIC INSTRUMENT CO., LTD.	+1.35%	+5.63%	-45.42%	-	952M
CARERAY DIGITAL MEDICAL TECHNOLOGY CO., LTD.	+17.03%	+10.93%	+29.15%	+99.38%	500M
CAPSOVISION, INC.	-1.79%	+1.39%	+68.29%	-	329M
FISCHER MEDICAL VENTURES LIMITED	+0.36%	+2.02%	-59.27%	+221.90%	265M
Average	+2.24%	+1.42%	-1.88%	+43.03%	2.62B
Weighted average by Cap.	+0.66%	+2.16%	-4.41%	-7.63%

	2022	2023
Net sales	8.27M 7.17M 6.68M 6.13M 11.59M 789M 11.74M 78.61M 30.83M 393M 31.07M 30.38M 1.3B	7.65M 6.63M 6.18M 5.67M 10.72M 730M 10.86M 72.71M 28.52M 364M 28.73M 28.1M 1.21B
Net income	-17.62M -15.26M -14.22M -13.06M -24.7M -1.68B -25.02M -167M -65.68M -837M -66.18M -64.72M -2.78B	-18.32M -15.87M -14.79M -13.58M -25.67M -1.75B -26.01M -174M -68.28M -871M -68.8M -67.28M -2.89B
Net Debt	1.76M 1.52M 1.42M 1.3M 2.46M 167M 2.49M 16.68M 6.54M 83.45M 6.59M 6.45M 277M	10.12M 8.77M 8.17M 7.5M 14.18M 965M 14.37M 96.16M 37.72M 481M 38M 37.17M 1.6B

End-of-day quote Nasdaq Other stock markets
- ^USD	-